Formulation and Drug Delivery

Astellas to Acquire Ganymed

November 02, 2016

Astellas will acquire Ganymed and its portfolio of ideal monoclonal antibody candidates.

FDA Advises Limited Clinical Testing for Biosimilars

November 02, 2016

The biosimilar pathway permits licensure based on less than full clinical data.

Oxford Genetics Secures GBP1 Million Investment for Gene Therapy Technologies

November 01, 2016

Oxford Genetics has secured a GBP1 million capital from investment group Mercia Technologies to support its growth strategy in delivering new services for cancer-fighting gene-therapy technologies.

Sanofi Pasteur Collaborates with WRAIR, Fiocruz on Zika Vaccine Development

October 27, 2016

The collaboration follows the signing of a cooperative research agreement between Sanofi Pasteur, Fiocruz, and WRAIR.

FDA Tackles Cellular, Gene Therapies

October 24, 2016

FDA’s new Office of Tissues and Advanced Therapies will oversee a growing range of cellular and genetic products.

Catalent Breaks Ground for Expanded Biologics Facility

October 24, 2016

PTSM: Pharmaceutical Technology Sourcing and Management

Catalent invests $34 million to add a 2 x 2000-L single-use bioreactor system and laboratory space in Madison, WI.